SAN DIEGO, CA, Oct. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® will partner with the non-profit organization The Por Grace Foundation. The partnership will be focused on raising awareness of the many potential benefits of cannabidiol (CBD) and donating CBD products to families in need.
“Giving back has always been a priority for Kannaway,” said Kannaway® CEO Blake Schroeder. “We have donated over $2 million in CBD products since inception and are proud to continue making an impact through Por Grace. We both have a shared vision to drive positive global change through education, support, and awareness of CBD.”
The Por Grace Foundation was founded in 2016 by Mayela Benavides Arriola and Raul Elizalde, the parents of Graciela Elizalde Benavides (Grace). After Grace was diagnosed with a rare and serious form of childhood epilepsy called Lennox-Gastaut Syndrome (LGS) at an early age, Raul began the family’s journey to discover ways to allow his daughter to live a more comfortable life -- which is how he found CBD. Almost immediately, Grace saw great success with CBD and Raul and his wife Mayela became motivated to make sure that she, as well as other families in need, could get legal access to CBD in Mexico.
The Foundation was able to get the first legal permits to import CBD in Mexico and now connects with families that need help making sure that their loved ones can access CBD as well. Por Grace also collaborates with research institutions, legislators, and CBD manufacturers to make sure that everyone has access to CBD products that have proven to be safe, high-quality, and consistent through third-party testing. Through educational seminars, fundraising efforts, and other events, Por Grace provides the general public with the knowledge they need to decide if CBD is right for them.
“We fought tirelessly to get Grace the CBD she needed and we want to make sure that other families don’t have the same challenges,” said Mayela Benavides Arriola, Grace’s Mother and Co-Founder of the Por Grace Foundation. “We are excited to partner with Kannaway to further our mission to break down accessibility and financial barriers for other families like ours that need CBD products and we are confident that this company, as well as its Brand Ambassadors, will do everything they can to help us further our efforts.”
To learn more about Kannaway® and its efforts to support Por Grace, please visit https://kannaway.com/por-grace.
About Kannaway®
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s corporate video, click here.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.
CONTACT:
Public Relations Contact:
Kathryn Brown
Account Director
CMW Media
P. 858-264-6600
kathryn@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
P. (858) 283-4016
Investors@medicalmarijuanainc.com
